Prenatal Whole Genome Sequencing: Just Because We Can, Should We?

Overview

Journal Hastings Cent Rep

Specialty Medical Ethics

Date 2012 Jul 11

PMID 22777977

Citations 23

Authors

Greer Donley

Sara Chandros Hull

Benjamin E Berkman

Affiliations

Soon will be listed here.

Citing Articles

Applications of genome sequencing as a single platform for clinical constitutional genetic testing.

Yang Y, Del Gaudio D, Santani A, Scott S Genet Med Open. 2025; 2():101840.

PMID: 39822265 PMC: 11736070. DOI: 10.1016/j.gimo.2024.101840.

Towards responsible ctDNA-based multi-cancer screening: a preliminary exploration and discussion of ethically relevant aspects.

Dondorp W, de Wert G Extracell Vesicles Circ Nucl Acids. 2024; 3(3):235-243.

PMID: 39697487 PMC: 11648474. DOI: 10.20517/evcna.2022.23.

Factors affecting couples' decision making about expanded prenatal cell-free DNA screening.

Mumford K, Hendriks S, Miner S, Huelsnitz C, Wakim P, Berkman B Genet Med Open. 2024; 2.

PMID: 39634380 PMC: 11613822. DOI: 10.1016/j.gimo.2024.101890.

A bacterial genome assembly and annotation laboratory using a virtual machine.

Trofimova E, Asgharzadeh Kangachar S, Weynberg K, Willows R, Jaschke P Biochem Mol Biol Educ. 2023; 51(3):276-285.

PMID: 36866633 PMC: 10947226. DOI: 10.1002/bmb.21720.

Expanded Non-invasive Prenatal Testing (NIPT) : Can the Child's Right to an Open Future Help Set the Scope?.

Claesen Z, Crombag N, Henneman L, Vermeesch J, Borry P J Bioeth Inq. 2023; 20(1):41-49.

PMID: 36630060 DOI: 10.1007/s11673-022-10222-7.

References

Andorno R . The right not to know: an autonomy based approach. J Med Ethics. 2004; 30(5):435-9. PMC: 1733927. DOI: 10.1136/jme.2002.001578. View

Burdick K, Lencz T, Funke B, Finn C, Szeszko P, Kane J . Genetic variation in DTNBP1 influences general cognitive ability. Hum Mol Genet. 2006; 15(10):1563-8. DOI: 10.1093/hmg/ddi481. View

Lawson K, Wiggins S, Green T, Adam S, Bloch M, Hayden M . Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing. J Med Genet. 1996; 33(10):856-62. PMC: 1050767. DOI: 10.1136/jmg.33.10.856. View

Sharp R . Downsizing genomic medicine: approaching the ethical complexity of whole-genome sequencing by starting small. Genet Med. 2011; 13(3):191-4. DOI: 10.1097/GIM.0b013e31820f603f. View

McGuire A, Lupski J . Personal genome research : what should the participant be told?. Trends Genet. 2010; 26(5):199-201. PMC: 2868334. DOI: 10.1016/j.tig.2009.12.007. View

. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001; 107(6):1451-5. DOI: 10.1542/peds.107.6.1451. View

Taylor Jr D, Cook-Deegan R, Hiraki S, Roberts J, Blazer D, Green R . Genetic testing for Alzheimer's and long-term care insurance. Health Aff (Millwood). 2010; 29(1):102-8. PMC: 2931337. DOI: 10.1377/hlthaff.2009.0525. View

Caulfield T, McGuire A, Cho M, Buchanan J, Burgess M, Danilczyk U . Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol. 2008; 6(3):e73. PMC: 2270329. DOI: 10.1371/journal.pbio.0060073. View

Went L . Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. J Med Genet. 1990; 27(1):34-8. PMC: 1016877. DOI: 10.1136/jmg.27.1.34. View

10.

Almqvist E, Bloch M, Brinkman R, Craufurd D, Hayden M . A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet. 1999; 64(5):1293-304. PMC: 1377865. DOI: 10.1086/302374. View

11.

Konrad M . Predictive genetic testing and the making of the pre-symptomatic person: Prognostic moralities amongst Huntington's-affected families. Anthropol Med. 2016; 10(1):23-49. DOI: 10.1080/13648470301269. View

12.

Bloch M, Adam S, Wiggins S, Huggins M, Hayden M . Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk. Am J Med Genet. 1992; 42(4):499-507. DOI: 10.1002/ajmg.1320420416. View

13.

Hull S, Prasad K . Reading between the lines: direct-to-consumer advertising of genetic testing. Hastings Cent Rep. 2001; 31(3):33-5. PMC: 4809519. View

14.

Ormond K, Wheeler M, Hudgins L, Klein T, Butte A, Altman R . Challenges in the clinical application of whole-genome sequencing. Lancet. 2010; 375(9727):1749-51. DOI: 10.1016/S0140-6736(10)60599-5. View

15.

BLACK R . A 1 and 6 month follow-up of prenatal diagnosis patients who lost pregnancies. Prenat Diagn. 1989; 9(11):795-804. DOI: 10.1002/pd.1970091108. View

16.

Mardis E . The impact of next-generation sequencing technology on genetics. Trends Genet. 2008; 24(3):133-41. DOI: 10.1016/j.tig.2007.12.007. View

17.

Alderson P, Sutcliffe K, Curtis K . Children's competence to consent to medical treatment. Hastings Cent Rep. 2007; 36(6):25-34. DOI: 10.1353/hcr.2006.0000. View

18.

Hall A, Bostanci A, Wright C . Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics. 2010; 13(4):246-55. DOI: 10.1159/000279626. View

19.

Harper P, Clarke A . Should we test children for "adult" genetic diseases?. Lancet. 1990; 335(8699):1205-6. DOI: 10.1016/0140-6736(90)92713-r. View

20.

Tarini B . The current revolution in newborn screening: new technology, old controversies. Arch Pediatr Adolesc Med. 2007; 161(8):767-72. DOI: 10.1001/archpedi.161.8.767. View